XBiotech Inc.
NASDAQ:XBIT
Overview | Financials
Company Name | XBiotech Inc. |
Symbol | XBIT |
Currency | USD |
Price | 3.89 |
Market Cap | 118,580,815 |
Dividend Yield | 0% |
52-week-range | 3.51 - 9.96 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. John Simard |
Website | https://www.xbiotech.com |
An error occurred while fetching data.
About XBiotech Inc.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD